|
CN111410654A
|
|
Synthesis of 3-bromo-5- (2-ethylimidazo [1,2-a ] pyridine-3-carbonyl) -2-hydroxybenzonitrile
|
|
CN111170963A
|
|
Application of 4- (benzoselenazole-2-yl) arylamine compound in treating gastric cancer
|
|
CN111170962A
|
|
Application of 4- (benzoselenazole-2-yl) arylamine compound in treating intestinal cancer
|
|
CN108084186A
|
|
URAT1 inhibitor and its application
|
|
CN107759588A
|
|
A kind of phenyl (base of pyrazolo [1,5 a] pyridine 3) ketone derivatives
|
|
CN106065010A
|
|
For treating or prevent the compound of hyperuricemia or gout
|
|
CN104817554A
|
|
Glucoside derivatives and pharmaceutical compositions thereof
|
|
CN104672227A
|
|
Novel SGLT2 inhibitor compounds and pharmaceutical composition thereof
|
|
CN104740797A
|
|
Respirator capable of filtering PM (particulate matters) 2.5 effectively
|
|
CN103801180A
|
|
Air purifier
|
|
CN104338512A
|
|
Silica aerogel prepared by using mixture of alkoxy silane
|
|
CN104338511A
|
|
Hydrophobic lipophilic silica aerogel taking alkoxy silane as raw material
|
|
CN103980267A
|
|
New xanthine oxidase inhibitor compound and pharmaceutical composition thereof
|
|
CN103848798A
|
|
2-Arylselenazole compounds and medicinal composition thereof
|
|
CN103848796A
|
|
Deuterium-substituted 2-phenylthiazole compound, and pharmaceutical composition thereof
|
